Description
Glucaric acid is the oxidized, non-cyclic form of a hexose sugar such as glucose. Glucaric acid derivatives exhibit anticancer chemotherapeutic and chemopreventive activities.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Glucaric acid is the oxidized, non-cyclic form of a hexose sugar such as glucose. Glucaric acid derivatives exhibit anticancer chemotherapeutic and chemopreventive activities.
| Cas No. | 5793-89-5 |
|---|---|
| Purity | ≥98% |
| Formula | C6H8O8Ca • 4H2O |
| Formula Wt. | 320.3 |
| IUPAC Name | calcium;(2S,3S,4S,5R)-2,3,4,5-tetrahydroxyhexanedioate;tetrahydrate |
| Synonym | D-Glucaric acid, calcium salt, D-Saccharic acid, calcium salt, Calcium D-glucarate |
| Melting Point | >250°C |
| Solubility | Insoluble in water. |
| Appearance | White Crystal Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Shiue E, Prather KL. Improving D-glucaric acid production from myo-inositol in E. coli by increasing MIOX stability and myo-inositol transport. Metab Eng. 2014 Mar;22:22-31. PMID: 24333274.
Smith TN, Hash K, Davey CL, et al. Modifications in the nitric acid oxidation of D-glucose. Carbohydr Res. 2012 Mar 1;350:6-13. PMID: 22285512.
Bespalov VG, Aleksandrov VA. Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors. Vopr Onkol. 2012;58(4):537-40. PMID: 23607211.
mAChR antagonist.
FIASMA; α1- and β1/2-adrenergic antagonist.
GSK-3 inhibitor.
NSAID; COX-1/2 and lipoxygenase inhibitor.
Pt-based DNA cross-linker.
Quinazolinone; mitochondrial division inhibitor...
Triterpenoid
Synthesis impurity
Anionic lipopeptide, alters cell membrane organ...
Camptothecin derivative; topoisomerase I inhibi...
Peptide fragment
Dihydropyridine; L-type Ca2+ channel blocker.
Potential anxiolytic.
Labdane diterpene found in Andrographolis; cNOS...
Quinoline, food preservative; HSP90 inhibitor.<...
BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor.
SMAC mimetic; PXR agonist, IAP inhibitor.
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Potential VEGFR2, Met, RET, Axl, Ron, PDGFR, FG...
Resveratrol prodrug; potential SIRT1 activator....